Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib and Dexamethasone in Refractory Autoimmune Cytopenia
NCT03965624Phase 2Withdrawn
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2019
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in immune thrombocytopenia (ITP), warm autoimmune hemolytic anemia (wAIHA), sponsored by Assistance publique - Hôpitaux de Paris. Planned start Sep 2019; status: withdrawn.
02
Drugs
ixazomib
03
Conditions
immune thrombocytopenia (ITP)warm autoimmune hemolytic anemia (wAIHA)
Beyond the preview
Go deeper on NCT03965624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03965624.